Post-Embolic Rhythm Detection With Implantable Versus External Monitoring

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 300 participants.

Also called NCT02428140

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose diagnostic
Phase
Not applicable
Enrolled
  • 300 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02428140
Main results
  • Effect of Implantable vs Prolonged External Electrocardiographic Monitoring on Atrial Fibrillation Detection in Patients With Ischemic Stroke: The PER DIEM Randomized Clinical Trial JAMA, 2021-06-01 DOI, PubMed 34061146, PMC8170545 Not in the PMC Open Access subset.

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
Canada (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02428140. Randomized; no masking; primary purpose diagnostic. Start 2015-07 (actual); primary completion 2018-12 (actual). Results posted on 2024-03-12.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Post-Embolic Rhythm Detection With Implantable Versus External Monitoring
Acronym
PERDIEM
Condition
Stroke
Condition
Arrhythmias, Cardiac
Intervention (Device)
Medtronic Reveal LINQ
Intervention (Device)
Sorin Spiderflash-t
Lead sponsor
University of Alberta (class: other)
Collaborator
University of Calgary (class: other)
Collaborator
Alberta Innovates Health Solutions (class: other)
Collaborator
Medtronic (class: industry)

Record details

Record id
cardio:ct-nct02428140
Content hash
c4d39d8b9d640dbdb2dd8d49e529345acc07525296ea0d9cf6194fcde33b8c7d